Category Archives: ANTI-DIABETIC DRUGS

GLIMEPIRIDE 2mg

glimepiride-glivarid-2mg

GLIVARID 2mg tablet; box of 40’s

Generic Name:Glimepiride
Registration Status: registered
Drug Type: ANTI-DIABETIC DRUGS
Principal:THE ACME LABORATORIES LTD

Description:
GLIVARID is Glimepiride an oral hypoglycemic drug belonging to the sulfonylurea group. It stimulates the release of insulin from functioning pancreatic ß-cells. It also can increase sensitivity of peripheral tissues to insulin. Indicated in type 2 diabetes mellitus when dietary modification has failed in adequate glycemic control. Available in blister pack of 10’s, box of 40’s.

GLIMEPIRIDE 3mg

glimepiride-glimesyn-3mg

GLIMESYN 3mg Tablet; box of 30’s

Generic Name:              Glimepiride
Registration Status:   Registered
Drug Type:                       ANTI-DIABETIC DRUGS
Principal:                         THE ACME LABORATORIES LTD.


Description:
GLIMESYN is Glimepiride an oral hypoglycemic drug belonging to the sulfonylurea group. It stimulates the release of insulin from functioning pancreatic ß-cells. It also can increase sensitivity of peripheral tissues to insulin. Indicated in type 2 diabetes mellitus when dietary modification has failed in adequate glycemic control.

Available in blister pack of 10’s, box of 30’s.

METFORMIN 500mg

metformin-hci-sucranorm-500mg

SUCRANORM 500mg Film-Coated Tablet; box of 100’s

Generic Name:              Metformin HCL
Registration Status:   Registered
Drug Type:                       ANTI-DIABETIC DRUGS
Principal:                         THE ACME LABORATORIES LTD.


Description:
The activity of Metformin Hydrochloride (Sucranorm) is different from that of Sulphonylurea. It reduces elevated blood glucose concentrations in patients with diabetes, but it does not increase insulin secretion. This is probably the reason why it does not cause hypoglycemia. Metformin seems to potentiate insulin action by enhancing insulin binding to its receptors and/or postreceptors. Metformin improves the blood lipoprotein profile not only in diabetics but also in non-diabetic subjects with hyperlipoproteinemia..

Available in Alu-PVDC Blister pack of 10’s, box of 100’s.

METFORMIN 850mg

metformin-hci-sucranorm-850mg

SUCRANORM 850mg Film-Coated Tablet; box of 40’s

Generic Name:              Metformin HCL
Registration Status:   Registered
Drug Type:                       ANTI-DIABETIC DRUGS
Principal:                         THE ACME LABORATORIES LTD.


Description:
The activity of Metformin Hydrochloride (Sucranorm) is different from that of Sulphonylurea. It reduces elevated blood glucose concentrations in patients with diabetes, but it does not increase insulin secretion. This is probably the reason why it does not cause hypoglycemia. Metformin seems to potentiate insulin action by enhancing insulin binding to its receptors and/or postreceptors. Metformin improves the blood lipoprotein profile not only in diabetics but also in non-diabetic subjects with hyperlipoproteinemia..

Available in Alu-PVDC Blister pack of 4’s , box of 40’s.

METFORMIN 1G

metformin-hci-sucranorm-1g

SUCRANORM 1g Film-Coated Tablet; box of 60’s

Generic Name:              Metformin HCL
Registration Status:   Registered
Drug Type:                       ANTI-DIABETIC DRUGS
Principal:                         THE ACME LABORATORIES LTD.


Description:
The activity of Metformin Hydrochloride (Sucranorm) is different from that of Sulphonylurea. It reduces elevated blood glucose concentrations in patients with diabetes, but it does not increase insulin secretion. This is probably the reason why it does not cause hypoglycemia. Metformin seems to potentiate insulin action by enhancing insulin binding to its receptors and/or postreceptors. Metformin improves the blood lipoprotein profile not only in diabetics but also in non-diabetic subjects with hyperlipoproteinemia..

Available in :  Alu-PVDC Blister pack of 10’s, box of 60’s.

PIOGLITAZONE

pioglitazone-ppar

PPAR 30mg tablet; box of 30’s

Generic Name:              Pioglitazone
Registration Status:   Registered
Drug Type:                       ANTI-DIABETIC DRUGS
Principal:                         BEXIMCO PHARMACEUTICALS LIMITED


Description:
PPAR is Pioglitazone an adjunct to diet and exercise to improve glycemic control in patients with Type II diabetes.

Available in blister pack of 10’s, box of 30’s.